Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...

The two biotechs, which have lost most of their share value following lucrative IPOs, are combining in a deal that leaves the ...

Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis ... Currently approved, or late-stage medicines being ...